BR1100548KB1 - processes for the preparation of crystalline n-acetyl neuraminic acid derivatives. - Google Patents

processes for the preparation of crystalline n-acetyl neuraminic acid derivatives.

Info

Publication number
BR1100548KB1
BR1100548KB1 BRPP1100548-KB1A BR1100548A BR1100548KB1 BR 1100548K B1 BR1100548K B1 BR 1100548KB1 BR 1100548 A BR1100548 A BR 1100548A BR 1100548K B1 BR1100548K B1 BR 1100548KB1
Authority
BR
Brazil
Prior art keywords
crystalline
processes
preparation
acid derivatives
neuraminic acid
Prior art date
Application number
BRPP1100548-KB1A
Other languages
Portuguese (pt)
Inventor
Christopher Williamson
William James White
Vipulkumar Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR1100548KB1 publication Critical patent/BR1100548KB1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPP1100548-KB1A 1993-12-17 1997-05-13 processes for the preparation of crystalline n-acetyl neuraminic acid derivatives. BR1100548KB1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325841A GB9325841D0 (en) 1993-12-17 1993-12-17 Chemical compounds

Publications (1)

Publication Number Publication Date
BR1100548KB1 true BR1100548KB1 (en) 2011-11-01

Family

ID=10746778

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9408340A BR9408340A (en) 1993-12-17 1994-12-15 5-acetamido-2,3,4,5-tetradeoxy-4-guanidino-d-glycero-d-glacto-non-2-enotyranosonic acid form critaline process for the preparation of these and pharmaceutical formulation
BRPP1100548-KB1A BR1100548KB1 (en) 1993-12-17 1997-05-13 processes for the preparation of crystalline n-acetyl neuraminic acid derivatives.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR9408340A BR9408340A (en) 1993-12-17 1994-12-15 5-acetamido-2,3,4,5-tetradeoxy-4-guanidino-d-glycero-d-glacto-non-2-enotyranosonic acid form critaline process for the preparation of these and pharmaceutical formulation

Country Status (43)

Country Link
US (2) US6294572B1 (en)
EP (1) EP0734382B1 (en)
JP (1) JP3317972B2 (en)
KR (1) KR100403256B1 (en)
CN (2) CN1502621A (en)
AP (2) AP9600810A0 (en)
AT (1) ATE199255T1 (en)
BG (1) BG63338B1 (en)
BR (2) BR9408340A (en)
CA (1) CA2177990C (en)
CO (1) CO4340619A1 (en)
CZ (1) CZ289234B6 (en)
DE (1) DE69426726T2 (en)
DK (1) DK0734382T3 (en)
EE (1) EE03353B1 (en)
EG (1) EG20597A (en)
ES (1) ES2155517T3 (en)
FI (1) FI120453B (en)
GB (1) GB9325841D0 (en)
GR (1) GR3035681T3 (en)
HR (1) HRP941001B1 (en)
HU (1) HU221971B1 (en)
IL (1) IL112011A (en)
IS (1) IS4240A (en)
MA (1) MA23396A1 (en)
MY (1) MY116221A (en)
NO (1) NO314759B1 (en)
NZ (1) NZ277789A (en)
OA (2) OA10325A (en)
PE (1) PE31095A1 (en)
PL (1) PL186384B1 (en)
PT (1) PT734382E (en)
RO (1) RO114792B1 (en)
RU (1) RU2134690C1 (en)
SA (1) SA94150417B1 (en)
SG (1) SG46669A1 (en)
SI (1) SI0734382T1 (en)
SK (1) SK282972B6 (en)
SV (1) SV1994000076A (en)
TW (1) TW452577B (en)
UA (1) UA46723C2 (en)
WO (1) WO1995016680A1 (en)
ZA (1) ZA9410003B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
CN100409844C (en) 1995-02-27 2008-08-13 吉里德科学公司 neuraminidase inhibitors
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
DE69709795T2 (en) * 1996-07-22 2002-09-26 Sankyo Co., Ltd. Neuraminic acid derivatives, their production and medical use
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI291462B (en) * 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
HK1199034A1 (en) * 2011-12-16 2015-06-19 Daiichi Sankyo Company, Limited Method for producing neuraminic acid derivative
CN109232677B (en) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 Method for converting N-acetylneuraminic acid hydrate into N-acetylneuraminic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU469694A1 (en) * 1972-12-22 1975-05-05 Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им.М.В.Ломоносова The method of obtaining 2-alkoxy-6-alkyl (aryl) - -dihydropyran
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
US5639786A (en) 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
BG63338B1 (en) 2001-10-31
RU2134690C1 (en) 1999-08-20
SI0734382T1 (en) 2001-08-31
MY116221A (en) 2003-12-31
AP9600810A0 (en) 1996-07-31
HU221971B1 (en) 2003-03-28
CN1142820A (en) 1997-02-12
TW452577B (en) 2001-09-01
EE03353B1 (en) 2001-02-15
GB9325841D0 (en) 1994-02-23
NO962545D0 (en) 1996-06-14
SK282972B6 (en) 2003-01-09
HK1014187A1 (en) 1999-09-24
HU9601642D0 (en) 1996-08-28
HRP941001A2 (en) 1997-06-30
CZ289234B6 (en) 2001-12-12
FI962464A0 (en) 1996-06-13
GR3035681T3 (en) 2001-06-29
FI120453B (en) 2009-10-30
PE31095A1 (en) 1995-10-18
SV1994000076A (en) 1995-10-26
DE69426726D1 (en) 2001-03-29
HRP941001B1 (en) 2001-06-30
EP0734382B1 (en) 2001-02-21
ES2155517T3 (en) 2001-05-16
CZ169396A3 (en) 1996-11-13
OA11275A (en) 2002-11-20
CA2177990A1 (en) 1995-06-22
AU1314495A (en) 1995-07-03
DK0734382T3 (en) 2001-03-19
JPH09506601A (en) 1997-06-30
FI962464L (en) 1996-06-13
IL112011A (en) 1998-08-16
AU689185B2 (en) 1998-03-26
CN1132829C (en) 2003-12-31
CO4340619A1 (en) 1996-07-30
KR100403256B1 (en) 2004-04-30
SA94150417B1 (en) 2005-12-18
NO962545L (en) 1996-06-14
PT734382E (en) 2001-06-29
SK78596A3 (en) 1997-03-05
UA46723C2 (en) 2002-06-17
HUT74938A (en) 1997-03-28
NO314759B1 (en) 2003-05-19
EP0734382A1 (en) 1996-10-02
JP3317972B2 (en) 2002-08-26
US20020037865A1 (en) 2002-03-28
MA23396A1 (en) 1995-07-01
IS4240A (en) 1995-06-18
AP541A (en) 1996-10-01
NZ277789A (en) 1999-04-29
EG20597A (en) 1999-09-30
RO114792B1 (en) 1999-07-30
WO1995016680A1 (en) 1995-06-22
IL112011A0 (en) 1995-03-15
AP9400705A0 (en) 1995-01-31
ATE199255T1 (en) 2001-03-15
ZA9410003B (en) 1995-07-25
BR9408340A (en) 1997-08-19
CA2177990C (en) 2000-04-25
SG46669A1 (en) 1998-02-20
BG100709A (en) 1997-01-31
OA10325A (en) 1997-10-07
CN1502621A (en) 2004-06-09
DE69426726T2 (en) 2001-06-21
PL315055A1 (en) 1996-09-30
US6294572B1 (en) 2001-09-25
PL186384B1 (en) 2004-01-30

Similar Documents

Publication Publication Date Title
FI960851L (en) Process for the preparation of N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
BR1100548KB1 (en) processes for the preparation of crystalline n-acetyl neuraminic acid derivatives.
FI954250L (en) Crystalline free ceftiofuric acid
DK0797542T3 (en) Process for the preparation of aluminosilicate derivatives
MX9204546A (en) PROCESS FOR THE PREPARATION OF NATAMYCIN BY FERMENTATION.
MX9205455A (en) PROCEDURE FOR THE PREPARATION OF CRYSTALLINE DIRYTHROMYCIN
ES2125463T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF N-ACETYL NEURAMINIC ACID.
MX9204635A (en) PROCEDURE FOR THE PREPARATION OF BETA-PHENYLISOSERINE DERIVATIVES.
MX9204521A (en) PROCESS FOR THE PREPARATION OF NATAMYCIN FOR FERMENTATION (CASE CH-1898).
MA23179A1 (en) PROCESS FOR THE PREPARATION OF A CRYSTALLINE MONOHYDRATE OF A SPIROSTANYLGLYCOSIDE
BR9503565A (en) Process for the preparation of a substituted or unsubstituted quinacridone
MA22401A1 (en) PROCESS FOR THE PREPARATION OF GUINOLEIN SALTS
MA21854A1 (en) PROCESS FOR THE PREPARATION OF PHOSPHONOMETHYL THIOETHOXYPURINES.
MX9204520A (en) PROCESS FOR THE PREPARATION OF NATAMYCIN BY FERMENTATION (CASE CH 2074).
MA21657A1 (en) PROCESS FOR THE PREPARATION OF PRECURSORS OF 3-ACYL-2- OXINDOLE-1- CARBOXAMIDES SELF-INFLAMMATORY.
MX9200841A (en) IMPROVED PROCESS FOR THE PREPARATION OF DINITROTOLUENE.
DE69616554D1 (en) SIALIC ACID DERIVATIVES
FI922125A7 (en) Microbiological process for the preparation of 5-hydroxypyrazinecarboxylic acid
BR9700009A (en) Process for the preparation of o-chloromethyl-phenylglyoxylic acid derivatives
EP0641764A3 (en) Process for the preparation of hydroxyalkylaminonitrobenzene derivatives.
FR2728566B1 (en) PROCESS FOR THE PREPARATION OF PENTENE-NITRILES
BR9811778B1 (en) process for the preparation of 1-phenylpyrazolin-3-carboxylic acid derivatives.
FR2687153B1 (en) PROCESS FOR THE PREPARATION OF (THENYL-2) -5 HYDANTOUINE.
BR9305542A (en) Process for the preparation of 5-alkoxy-2,4-dinitro-alkylbenzenes
AU6495298A (en) Process for preparing 3-hydroxy-3-methylbutyric acid or its salts